Carmine Valenza, Medical Oncology Resident at the European Institute of Oncology, shared a post on X:
“Just out on JAMA Network Open, our secondary analysis of extended ET in prem pts with eBC according to surrogate subtypes.
Take home: not only the stage but also biology matters when considering eET beyond 5y of LHRHa.
Pts w/ Lum A-like eBC appear to derive greater benefit.”
Title: Extended Endocrine Therapy and Survival for Breast Cancer Subtypes
in Premenopausal Patients
Authors: Carmine Valenza, Yue Zheng, Monica Milano, Pier Paolo Maria Berton Giachetti, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Julian Etessami, Nadia Bianco, Fabio Conforti, Gregory Kirkner, Claudia Sangalli, Kate Dibble, Nicola Fusco, Marco Colleoni, Meredith Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann Partridge
Other articles featuring Carmine Valenza on OncoDaily.
